Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Atorvastatin Decreases HBx-Induced Phospho-Akt in Hepatocytes via P2X Receptors.

Ghalali A, Martin-Renedo J, Högberg J, Stenius U.

Mol Cancer Res. 2017 Jun;15(6):714-722. doi: 10.1158/1541-7786.MCR-16-0373. Epub 2017 Feb 16.

2.

Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.

Carbajo-Pescador S, García-Palomo A, Martín-Renedo J, Piva M, González-Gallego J, Mauriz JL.

J Pineal Res. 2011 Nov;51(4):463-71. doi: 10.1111/j.1600-079X.2011.00910.x. Epub 2011 Jul 1.

PMID:
21718361
3.

Methionine aminopeptidases as potential targets for treatment of gastrointestinal cancers and other tumours.

Mauriz JL, Martín-Renedo J, García-Palomo A, Tuñón MJ, González-Gallego J.

Curr Drug Targets. 2010 Nov;11(11):1439-57. Review.

PMID:
20583970
4.

Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells.

Carbajo-Pescador S, Martín-Renedo J, García-Palomo A, Tuñón MJ, Mauriz JL, González-Gallego J.

J Pineal Res. 2009 Nov;47(4):330-8. doi: 10.1111/j.1600-079X.2009.00719.x. Epub 2009 Oct 10.

PMID:
19817970
5.

Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line.

Martín-Renedo J, Mauriz JL, Jorquera F, Ruiz-Andrés O, González P, González-Gallego J.

J Pineal Res. 2008 Nov;45(4):532-40. doi: 10.1111/j.1600-079X.2008.00641.x.

PMID:
19012662
6.

Changes in the antioxidant system by TNP-470 in an in vivo model of hepatocarcinoma.

Mauriz JL, Durán MC, Molpeceres V, Barrio JP, Martín-Renedo J, Culebras JM, González-Gallego J, González P.

Transl Res. 2007 Sep;150(3):189-96. Epub 2007 May 21.

PMID:
17761372
7.

[Experimental models on hemorragic shock].

Mauriz JL, Martín Renedo J, Barrio JP, Culebras JM, González P.

Nutr Hosp. 2007 Mar-Apr;22(2):190-8. Review. Spanish.

PMID:
17416035

Supplemental Content

Loading ...
Support Center